Lifitegrast: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Lifitegrast. Educational only — not medical advice.
Labeled uses
Xiidra ® (lifitegrast ophthalmic solution) 5% is indicated for the treatment of the signs and symptoms of dry eye disease (DED).
Source: FDA labeling via NIH DailyMed (set 1a914080…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.